ES2505643T3 - Galectina para uso en el tratamiento del síndrome del ojo seco - Google Patents
Galectina para uso en el tratamiento del síndrome del ojo seco Download PDFInfo
- Publication number
- ES2505643T3 ES2505643T3 ES06758319.5T ES06758319T ES2505643T3 ES 2505643 T3 ES2505643 T3 ES 2505643T3 ES 06758319 T ES06758319 T ES 06758319T ES 2505643 T3 ES2505643 T3 ES 2505643T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- dry eye
- galectin
- eye syndrome
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1732—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Una composición para su uso en el tratamiento o en la prevencion del ojo seco en un mamifero que necesite dicho tratamiento o prevencion, y ditha composición comprende una cantidad terapeuticamente eficaz de una proteina galectina.
Description
Claims (1)
-
imagen1 imagen2 imagen3 imagen4
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/104,677 US7189697B2 (en) | 2004-04-13 | 2005-04-13 | Compositions and uses of a galectin for treatment of dry eye syndrome |
US104677 | 2005-04-13 | ||
PCT/US2006/013785 WO2006113311A2 (en) | 2005-04-13 | 2006-04-13 | Compositions and uses of a galectin for treatment of dry eye syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2505643T3 true ES2505643T3 (es) | 2014-10-10 |
Family
ID=37115683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES06758319.5T Active ES2505643T3 (es) | 2005-04-13 | 2006-04-13 | Galectina para uso en el tratamiento del síndrome del ojo seco |
Country Status (9)
Country | Link |
---|---|
US (1) | US7189697B2 (es) |
EP (1) | EP1874337B1 (es) |
JP (1) | JP5146835B2 (es) |
KR (2) | KR101589742B1 (es) |
CN (1) | CN101500589B (es) |
CA (1) | CA2604583C (es) |
ES (1) | ES2505643T3 (es) |
MX (1) | MX2007012725A (es) |
WO (1) | WO2006113311A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6967021B2 (en) * | 2001-04-27 | 2005-11-22 | Trustees Of Tufts College | Use of Galectin-3 to promote the re-epithelialization of wounds |
US20070185014A1 (en) * | 2006-02-09 | 2007-08-09 | The Schepens Eye Research Institute, Inc. | Methods and compositions for modulating conjunctival goblet cells |
US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
ES2397441T5 (es) | 2006-02-13 | 2022-09-14 | Daiichi Sankyo Co Ltd | Secuencias polinucleotídicas y polipeptídicas implicadas en el proceso de remodelación ósea |
US20100330602A1 (en) * | 2006-09-19 | 2010-12-30 | Emory University | Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment |
GB0622694D0 (en) * | 2006-11-14 | 2006-12-27 | Serentis Ltd | Use of opioid compounds in wound healing |
AU2008247423B2 (en) | 2007-05-04 | 2013-10-31 | Abbott Medical Optics Inc. | Methods and devices for measuring tear film and diagnosing tear disorders |
EP2424535B1 (en) | 2009-04-28 | 2015-03-04 | Ian S. Zagon | Methods and compositions for treating dry eye |
US20110065643A1 (en) * | 2009-06-12 | 2011-03-17 | University Of Southern California | Clusterin Pharmaceuticals and Treatment Methods Using the Same |
KR102029951B1 (ko) | 2011-07-22 | 2019-11-08 | 베이징 베타 파머수티컬 컴퍼니 리미티드 | 프로릴 히드록실라제 억제제로서 화합물의 다형체형, 및 이의 용도 |
US9636355B2 (en) | 2011-09-22 | 2017-05-02 | Theo Holdings, Llc | Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion |
US20150237837A1 (en) * | 2012-06-18 | 2015-08-27 | Duke University | Non-Human Model for Wound Healing |
EP2875051B1 (en) | 2012-07-19 | 2019-02-20 | Daiichi Sankyo Company, Limited | Anti-siglec-15 antibodies |
WO2016122169A1 (ko) * | 2015-01-26 | 2016-08-04 | 주식회사 바이오코즈글로벌코리아 | 뉴레귤린을 포함하는 상처 또는 안구건조증의 치료용 약학 조성물 |
WO2017160884A1 (en) * | 2016-03-14 | 2017-09-21 | Capricor, Inc. | Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles |
US10456447B2 (en) * | 2016-10-05 | 2019-10-29 | Consejo Nacional de Investigacions Cientificas y Técnicas | Therapeutic modulation of skin immune system with Gal-7 |
US20210395333A1 (en) * | 2018-06-07 | 2021-12-23 | Palleon Pharmaceuticals Inc. | Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69730476T2 (de) * | 1996-04-19 | 2005-11-17 | Tsubota, Kazuo, Funabashi | Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen |
US5869289A (en) * | 1996-10-09 | 1999-02-09 | Incyte Pharmaceuticals, Inc. | Human galectin homolog |
AU9301998A (en) * | 1997-09-05 | 1999-03-22 | Board Of Regents Of The University Of Oklahoma, The | Composition and methods using galectin-1 |
AU2001243622A1 (en) * | 2000-03-13 | 2001-09-24 | La Jolla Institute For Allergy And Immunology | Monocyte chemoattractant activity of galectin-3 |
US6967021B2 (en) * | 2001-04-27 | 2005-11-22 | Trustees Of Tufts College | Use of Galectin-3 to promote the re-epithelialization of wounds |
US6770622B2 (en) * | 2001-06-08 | 2004-08-03 | Gary A. Jarvis | N-terminally truncated galectin-3 for use in treating cancer |
US20030109509A1 (en) * | 2001-10-11 | 2003-06-12 | Alcon, Inc. | Methods for treating dry eye |
-
2005
- 2005-04-13 US US11/104,677 patent/US7189697B2/en active Active
-
2006
- 2006-04-13 ES ES06758319.5T patent/ES2505643T3/es active Active
- 2006-04-13 EP EP06758319.5A patent/EP1874337B1/en not_active Not-in-force
- 2006-04-13 JP JP2008506673A patent/JP5146835B2/ja not_active Expired - Fee Related
- 2006-04-13 CA CA2604583A patent/CA2604583C/en not_active Expired - Fee Related
- 2006-04-13 MX MX2007012725A patent/MX2007012725A/es active IP Right Grant
- 2006-04-13 KR KR1020077023079A patent/KR101589742B1/ko not_active IP Right Cessation
- 2006-04-13 CN CN200680009189.4A patent/CN101500589B/zh not_active Expired - Fee Related
- 2006-04-13 WO PCT/US2006/013785 patent/WO2006113311A2/en active Application Filing
- 2006-04-13 KR KR1020147007733A patent/KR20140054347A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007012725A (es) | 2008-04-09 |
JP5146835B2 (ja) | 2013-02-20 |
EP1874337A4 (en) | 2010-07-14 |
US20060189514A1 (en) | 2006-08-24 |
WO2006113311A3 (en) | 2009-04-16 |
US7189697B2 (en) | 2007-03-13 |
KR20140054347A (ko) | 2014-05-08 |
CN101500589A (zh) | 2009-08-05 |
CA2604583A1 (en) | 2006-10-26 |
EP1874337A2 (en) | 2008-01-09 |
CA2604583C (en) | 2015-06-02 |
CN101500589B (zh) | 2014-06-18 |
EP1874337B1 (en) | 2014-09-03 |
KR20070119030A (ko) | 2007-12-18 |
KR101589742B1 (ko) | 2016-01-28 |
WO2006113311A2 (en) | 2006-10-26 |
JP2008536857A (ja) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2505643T3 (es) | Galectina para uso en el tratamiento del síndrome del ojo seco | |
ES2665917T3 (es) | Endoxifeno para su uso en el tratamiento del cáncer | |
ES2489741T3 (es) | Composición para la prevención de la aparición de acontecimientos cardiovasculares | |
ES2502472T3 (es) | Composición adhesiva para su uso en un inmunosensor | |
ES2575152T3 (es) | Combinación terapéutica y uso de anticuerpos antagonistas de DLL4 y agentes antihipertensores | |
CL2012000518A1 (es) | Uso de un anticuerpo aislado o fragmento de enlace antígeno del mismo que comprende una región variable de cadena ligera y una de cadena pesada (sec nº38 y nº40) útil en el tratamiento y prevención de mieloma en un mamífero (div. sol. 3615-07). | |
CY1118406T1 (el) | Μεθοδοι αγωγης συνδρομου down, συνδρομου ευθραυστου χ και αυτισμου | |
ECSP056229A (es) | Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres | |
ES2375373T5 (es) | Procedimiento y dispositivo para poner fuera de servicio puertas defectuosas | |
ES2603963T3 (es) | Composiciones y métodos para el tratamiento de trastornos renales | |
AR057643A1 (es) | Lacosamida para terapia adjunta | |
CL2008000795A1 (es) | Uso de 1-[2-(2,4-dimetilfenilsulfanil)fenil)piperazina para el tratamiento del dolor o de los sintomas residuales de la depresion; y dicho compuesto. | |
DE602005025289D1 (de) | Lichtquelle und dieselbe verwendende Belichtungsvorrichtung | |
BRPI0513944A (pt) | forma substancialmente pura de um composto de quinazolina, uso de um composto de quinazolina e composição | |
CL2007002494A1 (es) | Composicion farmaceutica que comprende una pirimidina trisustituida en combinacion con un compuesto con propiedades inhibitorias de pde5; y uso en el tratamiento de una enfermedad que involucre vasoconstriccion. | |
CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
ES2629309T3 (es) | Formulaciones de tratamiento de la mucositis inducida por terapia antitumoral o inmunosupresora | |
ES2633537T3 (es) | Placa de compuesto de madera y procedimiento para fabricarla | |
HRP20090336T1 (en) | Antitumor combinations containing vegf - trap and 5fu or one of its derivatives | |
RS50591B (sr) | Lek za lečenje gljivičnih infekcija, naročito aspergiloze | |
CY1108773T1 (el) | 7-υδροξυεπιανδροστερονη που εχει νευροπροστατευτικη δραση | |
JP2023175831A5 (es) | ||
JP2022122912A5 (es) | ||
ES2543836T3 (es) | Procedimientos y composiciones para el tratamiento de afecciones miocárdicas | |
BRPI0922908A2 (pt) | "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste". |